Filing Details

Accession Number:
0001209191-17-058481
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-31 18:18:06
Reporting Period:
2017-10-31
Accepted Time:
2017-10-31 18:18:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197032 F Ian Smith C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-31 1,700 $142.40 114,188 No 4 S Direct
Common Stock Disposition 2017-10-31 5,200 $143.47 108,988 No 4 S Direct
Common Stock Disposition 2017-10-31 32,945 $144.47 76,043 No 4 S Direct
Common Stock Disposition 2017-10-31 22,464 $145.26 53,579 No 4 S Direct
Common Stock Disposition 2017-10-31 5,200 $146.39 48,379 No 4 S Direct
Common Stock Disposition 2017-10-31 3,500 $147.40 44,879 No 4 S Direct
Common Stock Disposition 2017-10-31 3,791 $148.26 41,088 No 4 S Direct
Common Stock Disposition 2017-10-31 200 $149.34 40,888 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,306 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.75).
  3. Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $143.47 (range $142.91 to $143.85).
  5. Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.91 to $144.89).
  6. Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87).
  7. Open market sales reported on this line occurred at a weighted average price of $146.39 (range $145.30 to $146.92).
  8. Open market sales reported on this line occurred at a weighted average price of $147.40 (range $146.93 to $147.90).
  9. Open market sales reported on this line occurred at a weighted average price of $148.26 (range $147.93 to $148.70).